Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy

被引：51

作者：

Bouts, Antonia ^{[1
]}

Monnens, Leo ^{[2
]}

Davin, Jean-Claude ^{[1
]}

Struijk, Geertrude ^{[3
]}

Spanjaard, Lodewijk ^{[4
]}

机构：

[1] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Nephrol, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Med Ctr Nijmegen, Dept Physiol, Nijmegen, Netherlands

[3] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, Div Internal Med, NL-1105 AZ Amsterdam, Netherlands

[4] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands

来源：

PEDIATRIC NEPHROLOGY | 2011年 / 26卷 / 10期

关键词：

COMPLEMENT INHIBITOR ECULIZUMAB;

D O I：

10.1007/s00467-011-1929-3

中图分类号：

R72 [儿科学];

学科分类号：

100202 [儿科学];

摘要：

引用

页码：1919 / 1920

页数：2

共 9 条

[1]

AMC RIVM, 2010, BACT MEN NETH ANN RE

[2]

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria [J].

Brodsky, Robert A. ;

Young, Neal S. ;

Antonioli, Elisabetta ;

Risitano, Antonio M. ;

Schrezenmeier, Hubert ;

Schubert, Jorg ;

Gaya, Anna ;

Coyle, Luke ;

De Castro, Carlos ;

Fu, Chieh-Lin ;

Maciejewski, Jaroslaw P. ;

Bessler, Monica ;

Kroon, Henk-Andre ;

Rother, Russell P. ;

Hillmen, Peter .

BLOOD, 2008, 111 (04) :1840-1847

[3]

FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria [J].

Dmytrijuk, Andrew ;

Robie-Suh, Kathy ;

Cohen, Martin H. ;

Rieves, Dwaine ;

Weiss, Karen ;

Pazdur, Richard .

ONCOLOGIST, 2008, 13 (09) :993-1000

[4]

Prevention of meningococcal disease [J].

Gardner, Pierce .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1466-1473

[5]

Global epidemiology of meningococcal disease [J].

Harrison, Lee H. ;

Trotter, Caroline L. ;

Ramsay, Mary E. .

VACCINE, 2009, 27 :B51-B63

[6]

Meningococcal disease and its management in children [J].

Hart, C. Anthony ;

Thomson, Alistair P. J. .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7570) :685-690A

[7]

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria [J].

Hillmen, Peter ;

Elebute, Modupe ;

Kelly, Richard ;

Urbano-Ispizua, Alvaro ;

Hill, Anita ;

Rother, Russell P. ;

Khursigara, Gus ;

Fu, Chieh-Lin ;

Omine, Mitsuhiro ;

Browne, Paul ;

Rosse, Wendell .

AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (08) :553-559

[8]

Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2-to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile [J].

Memish, Ziad A. ;

Dbaibo, Ghassan ;

Montellano, May ;

Verghese, Valsan P. ;

Jain, Hemant ;

Dubey, A. P. ;

Bianco, Veronique ;

Van der Wielen, Marie ;

Gatchalian, Salvacion ;

Miller, Jacqueline M. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (04) :E56-E62

[9]

aHUS caused by complement dysregulation: new therapies on the horizon [J].

Waters, Aoife M. ;

Licht, Christoph .

PEDIATRIC NEPHROLOGY, 2011, 26 (01) :41-57

← 1 →